GoodRx Holdings Third Quarter 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Yahoo! Finance
EPS: US$0.01 (up from US$0.093 loss in 3Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 59%. Looking ahead, revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 9.8% growth forecast for the Healthcare Services industry in the US. Performance of the American Healthcare Services industry. The company's shares are down 21% from a week ago. You should always think about risks. Case in point, we've spotted 1 warning sign for GoodRx Holdings you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to b
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- Prof G's mother being ‘underinsured' fueled him to get rich — says America ‘focuses on shareholders' over wellbeing [Yahoo! Finance]Yahoo! Finance
- GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Seven Reasons Regular Health Checkups With Your Doctor Save You Money [Forbes]Forbes
- GoodRx Holdings, Inc. (NASDAQ: GDRX) had its price target lowered by analysts at Morgan Stanley from $7.00 to $6.00. They now have an "equal weight" rating on the stock.MarketBeat
- GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. CountiesBusiness Wire
GDRX
Earnings
- 11/7/24 - Beat
GDRX
Sec Filings
- 12/23/24 - Form 4
- 12/18/24 - Form SCHEDULE
- 12/18/24 - Form SCHEDULE
- GDRX's page on the SEC website